Healthcare data

LynxCare recognized among the World's Best Digital Health Companies

We are proud to share that we have been recognized as one of the World's Best Digital Health Companies by Newsweek and Statista!

Read the blog article
LynxCare appoints Jeanne Kehren to new CEO

LynxCare appoints Jeanne Kehren as new Chief Executive Officer. She succeeds Georges De Feu, LynxCare’s visionary founder, who stepped aside from his position as CEO.

Read the blog article
Former Chief Strategy Officer at Sanofi, Laurent van Lerberghe Joins LynxCare as Investor and Board Advisor

LynxCare is excited to announce the appointment of Laurent van Lerberghe, former Chief Strategy Officer at Sanofi, as Investor and Board Advisor. LynxCare is a scale-up company in Clinical Artificial Intelligence part of the CB Insights Global Digital Health 150, supported by renowned VC investors MTIP (CH), Elaia (FR), B2Ventures (CH-DE) and Heran partners (BE).

Read the blog article
Unlock Insights in Heart Failure

Through our comprehensive datasets, including an estimated 23.500 patients and 235 variables, you can gain further insights into the complexities of heart failure.

Read the blog article
Advancing Multiple Myeloma Research Through Unlocking Unstructured Hospital Data

Leveraging cutting-edge AI and disease-specific Clinical NLP, LynxCare unlocks the richness of hospital data (incl. narrative text in medical records - unstructured data), building harmonized databases. Hospitals and life sciences can in turn extract clinical insights from fresh Real-World Data for research and improving patient care.

Read the blog article
CLL Patient Journey Insights from Fresh Quality-Assured Real-World Data

Our granular and quality-controlled real-world dataset allows in-depth analysis and research into the CLL patient journey.

Read the blog article
Your platform for extensive breast cancer analysis and research – Explore LynxCare’s Breast Cancer Datasets

67% stage I-II breast cancer patients, 14% stage III-IV breast cancer patients - discover more LynxCare datasets insights.

Read the blog article
Analyze adverse events and treatment patterns in Immuno-Oncology through LynxCare's Real-World Datasets

Gain fresh insights into the relationship of specific comorbidities, adverse events and biomarkers with immuno-oncology prognosis through LynxCare's European data asset.

Read the blog article

Find answers to complex clinical questions.

We have a team of MDs, data scientists and software engineers ready to let data drive your outcomes.